Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2018

01-01-2018 | Correction

Correction to: Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials

Authors: S. C. Hayes, M. L. Steele, R. R. Spence, L. Gordon, D. Battistutta, J. Bashford, C. Pyke, C. Saunders, E. Eakin

Published in: Breast Cancer Research and Treatment | Issue 2/2018

Login to get access

Excerpt

In the original publication of the article, under the heading Discussion, 1st paragraph, the sentence that reads as, “Nonetheless, our observed improvements of over 50% for OS and over 30% for DFS (HRs: 0.45 and 0.66, respectively) are consistent with results from other available studies” should read as “Nonetheless, our observed improvements of over 50% for OS and DFS (HRs: 0.45 and 0.66, respectively) are consistent with results from other available studies.” …
Metadata
Title
Correction to: Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials
Authors
S. C. Hayes
M. L. Steele
R. R. Spence
L. Gordon
D. Battistutta
J. Bashford
C. Pyke
C. Saunders
E. Eakin
Publication date
01-01-2018
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2018
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4569-x

Other articles of this Issue 2/2018

Breast Cancer Research and Treatment 2/2018 Go to the issue

Epidemiology

Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990–2010

Clinical trial

A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.

Preclinical study

Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance

Epidemiology

Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt

Preclinical study

Ethnicity and breast cancer characteristics in Kenya

Clinical trial

Usefulness of abbreviated breast MRI screening for women with a history of breast cancer surgery
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits